Christina Kyzirakos

Adoptive Transfer of Epstein-Barr Virus (EBV) Nuclear Antigen 1–Specific T Cells As Treatment for EBV Reactivation and Lymphoproliferative Disorders After Allogeneic Stem-Cell Transplantation

Vanya Icheva, Simone Kayser, Daniel Wolff et al. · Journal of Clinical Oncology · 2012 · 269 citations · Full text

Life Sciences, Hematology, Immunology +14

Pediatric posttransplant relapsed/refractory B-precursor acute lymphoblastic leukemia shows durable remission by therapy with the T-cell engaging bispecific antibody blinatumomab

P. Schlegel, Peter Lang, Gerhard Zugmaier et al. · Haematologica · 2014 · 134 citations · Full text

Medicine, Hematology, Oncology +17

Circulating CD4+ T Cells That Produce IL4 or IL17 When Stimulated by Melan-A but Not by NY-ESO-1 Have Negative Impacts on Survival of Patients with Stage IV Melanoma

Henning Zelba, Benjamin Weide, Alexander Martens et al. · Clinical Cancer Research · 2014 · 41 citations · Full text

Life Sciences, Immunology, Oncology +17

Use of plasma ctDNA as a potential biomarker for longitudinal monitoring of a patient with metastatic high-risk upper tract urothelial carcinoma receiving pembrolizumab and personalized neoepitope-derived multipeptide vaccinations: a case report

Carolin Blumendeller, Julius Boehme, Maximilian Frick et al. · Journal for ImmunoTherapy of Cancer · 2021 · 19 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Favorable NK cell activity after haploidentical hematopoietic stem cell transplantation in stage IV relapsed Ewing’s sarcoma patients

Paul-Gerhard Schlegel, Tobias Feuchtinger, C Nitschke-Gérard et al. · Bone Marrow Transplantation · 2015 · 17 citations

Medicine, Hematology, Oncology +14